Market intelligence, campaigns and governed AI adoption for the most complex commercial environment in B2B
Healthcare buying is unlike buying anywhere else. Every decision passes through clinicians, technologists, finance leaders, procurement teams and regulators, each with different priorities, evidence requirements and definitions of value. Product strength alone does not win in this market. Commercial precision does, and building that precision for healthcare organizations is the work we do every day
The evidence behind the challenges every healthcare commercial team is facing right now
of recent biopharma launches missed their peak revenue targets
of healthcare organizations have more AI pilots than they can scale
of healthcare organizations worry about keeping pace with regulation, while under a third feel
stakeholder groups hold influence or veto in a typical healthcare buying decision
New geographies and segments, from national health systems to regulated payer environments, where access is controlled by structures that product quality alone cannot unlock. Entering without intelligence costs quarters, not weeks
Technically strong propositions that fail to land because the message speaks to features while clinicians, payers and procurement teams are asking one question: what outcome does this deliver, and for whom
Campaigns built for a single buyer in a market where CIOs, clinical leaders, CFOs, CISOs, procurement and health authority program leads can each stop a deal the campaign never spoke to
Regulatory review cycles that stall campaigns at the finish line and erode commercial impact. Compliance designed in from the first brief is faster than compliance bolted on at the end
Pressure from the board to adopt AI, matched by legitimate concerns about explainability, data privacy and clinical governance. Most pilots stall here. Governed adoption is what moves them forward
Healthcare organizations are data rich and insight poor. Prescribing data, pipeline trackers and research subscriptions pile up while strategic decisions are still made on instinct, investment flows to the wrong segments, and campaigns are built on outdated assumptions about how buyers actually decide
The nine-box model is three capabilities, market intelligence, campaigns and AI, each delivered across three layers: the core
offering, the technology that powers it and the training that embeds it in your team. In healthcare, the model
matters because the problems are never singular. Market dynamics, regulatory constraint, clinical credibility
and commercial pressure arrive together, so the answer has to be connected too.
Healthcare organizations are data rich and insight poor. Prescribing data, pipeline trackers and research subscriptions pile up while strategic decisions are still made on instinct, investment flows to the wrong segments, and campaigns are built on outdated assumptions about how buyers actually decide
Healthcare campaign failures follow a pattern. The audience is defined too broadly, the message leads with features, and compliance review arrives at the end, creating rework cycles that delay launch and drain impact. The result is marketing spend that generates impressions while the pipeline stays flat
Nearly every healthcare organization has tried something: a pilot, a subscription, a vendor proof of concept. Most have stalled, and the failure mode is consistent. The use case was chosen for technology interest rather than commercial value, the governance was not built for a regulated environment, and nobody trained the team to use it
Client confidentiality matters in this market, so these engagements are anonymized. The work, the regions and the outcomes are real
A MedTech organization preparing to enter Japan needed to understand the regulatory pathway, the buyer landscape and where to compete first. We delivered decision ready intelligence that shaped the entry strategy before a single commercial commitment was made
A national scale health data platform needed a campaign strategy that could speak credibly to government, clinical and technology stakeholders at once. We built the stakeholder map, the message architecture and the campaign plan for a buying group where every audience holds influence
A leading international healthcare events business needed market intelligence and a stronger commercial capability in the same program. We combined the two, so the intelligence informed the sales approach and the team was trained to keep using both
NXT Horizon is the knowledge partner at four flagship healthcare and life sciences events this year, and a strategic partner to the
organizations behind them. At each one we are speaking, hosting roundtables and publishing dedicated research for that market
Every event has its own NXT Horizon page with the resources we have developed for it.
Commercial growth for MedTech companies entering and scaling across APAC.
Bridging digital health innovation and real world commercial adoption in the GCC
Commercializing health innovation across the UK health and longevity ecosystem
Pharma and biotech commercial growth in Saudi Arabia’s industrial transformation
Commercial growth for MedTech companies entering and scaling across APAC.
Seeing us at an event this year?
Research, predictions, event briefs and practical guides from our healthcare practice. Read online or download
Where healthcare commercialization is heading next, and what commercial leaders should do about it now
Published for MedTech World Asia
Published for WHX Tech
Anonymized use case
Published for MedTech World Asia
Published for WHX Tech
Anonymized use case
